A systematic review and meta-regression analysis on the impact of increasing IgG trough level on infection rates in primary immunodeficiency patients on intravenous …
JL Lee, N Mohamed Shah, M Makmor-Bakry… - Journal of clinical …, 2020 - Springer
Purpose We conducted a systematic review and meta-regression analysis to evaluate the
impact of increasing immunoglobulin G (IgG) trough levels on the clinical outcomes in …
impact of increasing immunoglobulin G (IgG) trough levels on the clinical outcomes in …
Home versus outpatient hospital intravenous immunoglobulin infusion and health care resource utilization
J Rastegar, VT Brown, I John, SW Dixon… - Journal of the American …, 2023 - Elsevier
Background Home health care delivery is projected to increase. Intravenous
immunoglobulin (IVIG) therapy has high potential to move from the outpatient hospital (OPH) …
immunoglobulin (IVIG) therapy has high potential to move from the outpatient hospital (OPH) …
Safety of intravenous immune globulin in an outpatient setting for patients with neuromuscular disease
W Waheed, GA Ayer, CL Jadoo, GJ Badger… - Muscle & …, 2019 - Wiley Online Library
Introduction Although intravenous immune globulin (IVIg) is used to treat patients in the
outpatient setting, there is limited documentation addressing the safety of this practice …
outpatient setting, there is limited documentation addressing the safety of this practice …
Effect of the ExactCare medication care management model on adherence, health care utilization, and costs
BACKGROUND: Multimorbidity and polypharmacy are common in the United States and are
associated with greater risk of disease-related complications and higher health care costs …
associated with greater risk of disease-related complications and higher health care costs …
Latent therapeutic demand model for the immunoglobulin replacement therapy of primary immune deficiency disorders in the USA
JS Stonebraker, J Hajjar, JS Orange - Vox Sanguinis, 2018 - Wiley Online Library
Background and Objectives Our research aim is to model latent therapeutic demand (LTD)
for the immunoglobulin replacement therapy (Ig GRT) of primary immune deficiency …
for the immunoglobulin replacement therapy (Ig GRT) of primary immune deficiency …
Outcome evaluation of a subcutaneous immunoglobulin clinical management program
J Zhu, G Ayer, HS Kirkham, CC Chen… - Journal of Research …, 2019 - journals.lww.com
Objective: The aim of this study is to compare clinical and cost outcomes of patients
undergoing subcutaneous immunoglobulin (SCIG) therapy who were managed by a clinical …
undergoing subcutaneous immunoglobulin (SCIG) therapy who were managed by a clinical …
Effect of the ExactCare medication care management model on adherence, health care utilization, and costs
HH Liu - DAYS, 2021 - jmcp.org
ABSTRACT BACKGROUND: Multimorbidity and polypharmacy are common in the United
States and are associated with greater risk of diseaserelated complications and higher …
States and are associated with greater risk of diseaserelated complications and higher …